Sachin Pawar | Pharmacology, Toxicology and Pharmaceutical Science | Innovative Research Award

Published on by Best Achievements

Innovative Research Award

Sachin Pawar
Manipal College of Pharmaceutical Sciences
Sachin Pawar
Affiliation Manipal College of Pharmaceutical Sciences
Country India
Scopus ID 57314689000
Documents 22
Citations 181
h-index 8
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event Global Best Achievements Awards
ORCID 0000-0002-9085-029X

Sachin Pawar is affiliated with Manipal College of Pharmaceutical Sciences in India and is associated with research in pharmacology, toxicology, and pharmaceutical science. The supplied research profile records 22 documents, 181 citations, and an h-index of 8, providing bibliometric indicators of documented scholarly activity and citation visibility within the relevant research areas.

Abstract

Sachin Pawar is a pharmaceutical sciences researcher affiliated with Manipal College of Pharmaceutical Sciences, India. His documented academic profile is associated with pharmacology, toxicology, and pharmaceutical science, fields concerned with the study of therapeutic substances, biological effects, safety, and pharmaceutical applications. The supplied research record reports 22 documents, 181 citations, and an h-index of 8, providing quantitative indicators of scholarly publication and citation activity. These measures offer a concise representation of research visibility but should be interpreted within disciplinary and publication contexts. His ORCID and Scopus identifiers provide additional mechanisms for distinguishing and documenting his scholarly research profile. [1]

Keywords

Sachin Pawar; Innovative Research Award; pharmacology; toxicology; pharmaceutical science; pharmaceutical research; drug research; biomedical research; research innovation; scholarly impact; academic research.

Introduction

Pharmaceutical sciences encompass multiple research disciplines concerned with medicines, their biological effects, safety, formulation, and therapeutic applications. Pharmacology and toxicology contribute to understanding drug actions and potential adverse effects, while pharmaceutical science connects these areas with the development and evaluation of medicinal products. Within this broader academic context, Sachin Pawar’s supplied profile identifies his subject area as Pharmacology, Toxicology and Pharmaceutical Science and documents an indexed research record. [1]

Research Profile

Sachin Pawar is affiliated with Manipal College of Pharmaceutical Sciences in India. The supplied Scopus profile identifies the researcher through Author ID 57314689000 and records 22 documents, 181 citations, and an h-index of 8. His ORCID identifier, 0000-0002-9085-029X, provides a persistent researcher identifier that can support accurate attribution of scholarly works across research systems. [1] [2]

Research Contributions

The available profile places Pawar’s scholarly activity within pharmacology, toxicology, and pharmaceutical science. These areas collectively address the mechanisms, effects, safety, and pharmaceutical applications of therapeutic substances. Because detailed publication titles, experimental findings, methodologies, and individual research projects were not supplied, specific scientific contributions cannot be attributed beyond the documented subject-area classification and available research profile.

Publications

The supplied Scopus information records 22 documents associated with Sachin Pawar’s research profile. This publication count provides a quantitative indication of indexed scholarly output. The available information does not include the complete publication bibliography, individual article titles, journal details, publication years, citation distribution, or DOI identifiers for Pawar’s specific works; therefore, no individual publication is attributed here without supporting source information. [1]

Research Impact

The supplied profile reports 181 citations across 22 documents and an h-index of 8. Citation counts provide a measurable indication of how frequently published research has been cited, while the h-index combines publication and citation information into a single bibliometric indicator. Such measures can assist in describing scholarly visibility but do not independently capture research quality, originality, methodological value, or broader societal impact. [3]

Award Suitability

The documented research profile is relevant to an Innovative Research Award through its association with pharmacology, toxicology, and pharmaceutical science and through the recorded scholarly output. The available bibliometric information establishes a measurable publication and citation record, while a complete award assessment would additionally consider the originality, significance, methodology, applicability, and documented outcomes of the researcher’s individual contributions.

Conclusion

Sachin Pawar’s supplied academic profile documents research activity in pharmacology, toxicology, and pharmaceutical science, supported by 22 indexed documents, 181 citations, and an h-index of 8. His affiliation with Manipal College of Pharmaceutical Sciences and identifiable Scopus and ORCID profiles provide a documented foundation for presenting his scholarly record. Further assessment of specific innovative contributions would require detailed publication-level and research-output evidence.

References

  1. Elsevier. (n.d.). Scopus Author Profile: Sachin Pawar, Author ID 57314689000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57314689000
  2. ORCID. (n.d.). Sachin Pawar, ORCID 0000-0002-9085-029X. ORCID.
    https://orcid.org/0000-0002-9085-029X
  3. Sachin Dattram Pawar. (2026). Cell and Gene Therapies Manufacturing Challenges and Integrated Good Manufacturing Practices Solutions: A Lifecycle Perspective.
    https://doi.org/10.1002/bit.70361
  4. Global Best Achievements Awards. (2026). Official Award Website.
    https://bestachievements.com/

Rashid Munir | Pharmaceutical Technology | Best Researcher Award

Published on by Best Achievements

Mr. Rashid Munir | Pharmaceutical Technology | Best Researcher Award 

Marburg University | Germany

Dr. Rashid Munir is an enthusiastic PhD researcher specializing in multifunctional nanocarriers for the co-delivery of drugs and genes, currently pursuing his doctoral research at Philipps University of Marburg, Germany. His research focuses on developing lipid-based nanocarriers, including liposomes and lipopolyplexes, for enhanced gene therapy and drug delivery in tumor models. He has extensive expertise in nanomedicine formulation, gene and drug delivery systems, and advanced physico-chemical characterization methods such as MTT, pGFP transfection, DLS, and confocal laser scanning microscopy. His technical proficiency extends to polymeric nanoparticles, dual drug–gene delivery systems, and analytical software such as ImageJ, GraphPad Prism, Origin, and Zetasizer Nano. Dr. Munir’s academic foundation includes an MPhil in Pharmaceutics from Quaid-i-Azam University, Islamabad, and a Doctor of Pharmacy (Pharm-D) from the University of Peshawar. He has published two peer-reviewed scientific articles and authored a master’s thesis on targeted drug delivery for rheumatoid arthritis. His research contributions, cited 48 times across 48 documents, demonstrate a growing impact in the fields of nanomedicine and targeted therapeutics, with an h-index of 1. Beyond research, he has served as a Pharmacist at Tianshi International and a Research Assistant at Quaid-i-Azam University, where he gained valuable experience in formulation design, in vitro assays, and academic mentoring. His commitment to innovation and translational research continues to drive advancements in drug delivery, gene therapy, and cancer nanotechnology

Profile: Scopus 

Featured Publications 

Schöne, L., Klein, S. C., Schorr, D., Preis, E., Engelhardt, K., Diemer, S., Munir, R., Schlüter, S., Schäfer, J., & Bakowsky, U. (2025). Optimizing the antimicrobial photodynamic efficacy of curcumin liposomes to treat pulmonary infections caused by gram-positive bacteria. European Journal of Pharmaceutical Sciences.

Lucas Villas Bôas Hoelz | Medicinal Chemistry | Best Researcher Award

Published on by Best Achievements

Prof. Dr. Lucas Villas Bôas Hoelz | Medicinal Chemistry | Best Researcher Award

Prof. Dr. Lucas Villas Bôas Hoelz, Instituto Federal do Rio de Janeiro, IFRJ, Brazil.

🧪 Prof. Dr. Lucas Villas Boas Hoelz is a distinguished chemist and researcher specializing in medicinal chemistry, molecular modeling, and organic synthesis. He earned his Ph.D. in Chemistry from the Federal University of Rio de Janeiro (UFRJ) and is a professor at the Federal Institute of Rio de Janeiro (IFRJ). As the coordinator of the Computational Medicinal Chemistry Laboratory (LCQM), his research focuses on COVID-19, neglected diseases, AIDS, and cancer. His contributions have significantly advanced therapeutic drug discovery and molecular dynamics. 🏆

Professional Profile

🎓 Early Academic Pursuits

Prof. Dr. Lucas Villas Boas Hoelz embarked on his academic journey with a strong foundation in Pharmacy at the Universidade Federal do Rio de Janeiro (UFRJ), graduating in 2004. He later pursued a Master’s degree (2007) and a Doctorate (2011) in Chemistry at UFRJ. His doctoral research focused on the theoretical study of beta1-adrenoceptor activation mediated by R-noradrenaline, under the supervision of Ricardo Bicca de Alencastro. He further expanded his expertise through postdoctoral studies at UFRJ and the Programa de Pós-Graduação em Ciências Aplicadas a Produtos para a Saúde (PPG-CAPS), solidifying his expertise in medicinal chemistry and computational modeling.

💼 Professional Endeavors

Dr. Hoelz has held multiple roles in academia and research. He currently serves as a Professor at the Instituto Federal do Rio de Janeiro (IFRJ) and is the coordinator of the Computational Medicinal Chemistry Laboratory (LCQM) at Campus Pinheiral-IFRJ. His professional trajectory includes positions as a temporary professor, tutor, and research fellow at various institutions. He has also contributed to postgraduate education as a permanent faculty member and graduate program mentor.

🔬 Contributions and Research Focus On Medicinal Chemistry

Dr. Hoelz specializes in Medicinal Chemistry, Organic Synthesis, Molecular Modeling, and Molecular Dynamics of Biological Systems. His research primarily addresses COVID-19, neglected diseases, AIDS, and cancer, focusing on the computational and experimental design of bioactive compounds. His work integrates comparative protein modeling, protein dynamics, and synthesis of new therapeutic agents, significantly advancing drug discovery efforts.

🌍 Impact and Influence

Through his research and academic contributions, Dr. Hoelz has played a key role in developing novel drug candidates and therapeutic strategies. His investigations into molecular interactions and drug mechanisms have informed the development of treatment methodologies for major global health concerns. His work has influenced both the scientific community and pharmaceutical industry, fostering innovation in medicinal chemistry.

📚 Academic Citations

Dr. Hoelz’s research has been widely recognized and cited in various peer-reviewed journals and academic conferences. His studies on molecular modeling, organic synthesis, and drug discovery have garnered substantial academic interest, reflecting the impact and relevance of his work in the field of medicinal chemistry.

🏅 Awards and Honors

Dr. Hoelz has received multiple scholarships and fellowships from prestigious organizations, including the Coordination for the Improvement of Higher Education Personnel (CAPES) and the National Council for Scientific and Technological Development (CNPq). His work has been recognized for its contributions to medicinal chemistry, with awards highlighting his excellence in research and teaching.

🚀 Legacy and Future Contributions

With a distinguished career in computational medicinal chemistry, Dr. Hoelz continues to expand his contributions by mentoring the next generation of researchers, publishing influential studies, and advancing computational approaches in drug design. His leadership at the LCQM ensures ongoing research in biomedical innovation, shaping the future of medicinal chemistry and molecular dynamics.

Publications Top Notes

🦠 Antiviral Research

1️⃣ The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
📜 Scientific Reports 7 (1), 40920
📅 2017 | 🔢 250 citations

2️⃣ Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo
📜 PLoS Neglected Tropical Diseases 13 (1), e0007072
📅 2019 | 🔢 113 citations

3️⃣ In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2
📜 Journal of Antimicrobial Chemotherapy 76 (7), 1874-1885
📅 2021 | 🔢 110 citations

4️⃣ Beyond Members of the Flaviviridae Family, Sofosbuvir Also Inhibits Chikungunya Virus Replication
📜 Antimicrobial Agents and Chemotherapy 63 (2), 10.1128/aac.01389-18
📅 2019 | 🔢 103 citations

🦟 Malaria & Parasitic Disease Research

5️⃣ Evaluation of 7-arylaminopyrazolo [1, 5-a] pyrimidines as anti-Plasmodium falciparum inhibitors
📜 European Journal of Medicinal Chemistry 126, 72-83
📅 2017 | 🔢 77 citations

6️⃣ Plasmodium Falciparum Dihydroorotate Dehydrogenase: A Drug Target against Malaria
📜 Future Medicinal Chemistry 10 (15), 1853-1874
📅 2018 | 🔢 55 citations

7️⃣ Comparative study between anti-P. falciparum activity of triazolopyrimidine, pyrazolopyrimidine, and quinoline derivatives
📜 European Journal of Medicinal Chemistry 209, 112941
📅 2021 | 🔢 34 citations

🧪 Medicinal & Pharmaceutical Chemistry

8️⃣ Pyrroles as privileged scaffolds in the search for new potential HIV inhibitors
📜 Pharmaceuticals 14 (9), 893
📅 2021 | 🔢 54 citations

9️⃣ Receptor-dependent (RD) 3D-QSAR approach of benzylpiperidine inhibitors of human acetylcholinesterase
📜 European Journal of Medicinal Chemistry 46 (1), 39-51
📅 2011 | 🔢 32 citations

🔟 New pyrazolopyrimidine derivatives as Leishmania amazonensis arginase inhibitors
📜 Bioorganic & Medicinal Chemistry 27 (14), 3061-3069
📅 2019 | 🔢 22 citations

🦠 Other Infectious Disease Research

1️⃣1️⃣ Structural and Functional Analysis of a Platelet-Activating Lysophosphatidylcholine of Trypanosoma cruzi
📜 PLoS Neglected Tropical Diseases 8 (8), e3077
📅 2014 | 🔢 36 citations

1️⃣2️⃣ New 1,2,3‐triazole‐based analogues of benznidazole for use against Trypanosoma cruzi infection
📜 Medicinal Chemistry Research
📅 Year N/A | 🔢 Citations N/A

🔬 Computational & Molecular Research

1️⃣3️⃣ Molecular dynamics simulations of the free and inhibitor-bound cruzain systems in aqueous solvent
📜 Journal of Biomolecular Structure and Dynamics 34 (9), 1969-1978
📅 2016 | 🔢 20 citations

1️⃣4️⃣ P2X7 receptor inhibition by 2-amino-3-aryl-1,4-naphthoquinones
📜 Bioorganic Chemistry 104, 104278
📅 2020 | 🔢 18 citations

🏥 Cancer & Leukemia Research

1️⃣5️⃣ Imatinib derivatives as inhibitors of K562 cells in chronic myeloid leukemia
📜 Medicinal Chemistry Research 26, 2929-2941
📅 2017 | 🔢 17 citations

🏗️ Green Chemistry & Synthesis

1️⃣6️⃣ Solvent Free, Microwave Assisted Conversion of Aldehydes into Nitriles and Oximes
📜 Molecules 15 (1), 94-99
📅 2009 | 🔢 17 citations